Clinical Usefulness of Serum CA 125 in Patients with Endometriosis

健太郎 高橋, 裕子 永田, 由夫 山根, 和男 吉野, 敏彦 渋川, 文規 村尾, 学 北尾
In: Shimane journal of medical science · 1986 · vol. 9(2) , pp. 82–88 · W7145187023
article OA: green CC0
🔓 Open OA copy View on OpenAlex

Abstract

Serum CA 125 levels in patients with endometriosis were elevated (35 U/ml or higher) in 88.9% (32/36). CA 125 levels correlated well with the response to Danazol treatment. Using this marker, myoma uteri and adenomyosis can be differentiated pre-operatively and the follow up with Danazol treatment in patients with endometriosis can be monitored.

My notes (saved in your browser only)

Condition tags

endometriosisadenomyosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK